168 related articles for article (PubMed ID: 8076689)
1. Identification and hypotensive activity of proadrenomedullin N-terminal 20 peptide (PAMP).
Kitamura K; Kangawa K; Ishiyama Y; Washimine H; Ichiki Y; Kawamoto M; Minamino N; Matsuo H; Eto T
FEBS Lett; 1994 Aug; 351(1):35-7. PubMed ID: 8076689
[TBL] [Abstract][Full Text] [Related]
2. Purification and characterization of PAMP-12 (PAMP[9-20]) in porcine adrenal medulla as a major endogenous biologically active peptide.
Kuwasako K; Kitamura K; Ishiyama Y; Washimine H; Kato J; Kangawa K; Eto T
FEBS Lett; 1997 Sep; 414(1):105-10. PubMed ID: 9305741
[TBL] [Abstract][Full Text] [Related]
3. Human proadrenomedullin N-terminal 20 peptide in pheochromocytoma and normal adrenal medulla.
Kuwasako K; Kitamura K; Ichiki Y; Kato J; Kangawa K; Matsuo H; Eto T
Biochem Biophys Res Commun; 1995 Jun; 211(2):694-9. PubMed ID: 7794284
[TBL] [Abstract][Full Text] [Related]
4. Immunoreactive proadrenomedullin N-terminal 20 peptide in human tissue, plasma and urine.
Washimine H; Kitamura K; Ichiki Y; Yamamoto Y; Kangawa K; Matsuo H; Eto T
Biochem Biophys Res Commun; 1994 Jul; 202(2):1081-7. PubMed ID: 8048921
[TBL] [Abstract][Full Text] [Related]
5. Increased plasma proadrenomedullin N-terminal 20 peptide in patients with essential hypertension.
Kuwasako K; Kitamura K; Kangawa K; Ishiyama Y; Kato J; Eto T
Ann Clin Biochem; 1999 Sep; 36 ( Pt 5)():622-8. PubMed ID: 10505213
[TBL] [Abstract][Full Text] [Related]
6. Hypotensive effect of a newly identified peptide, proadrenomedullin N-terminal 20 peptide.
Shimosawa T; Fujita T
Hypertension; 1996 Sep; 28(3):325-9. PubMed ID: 8794811
[TBL] [Abstract][Full Text] [Related]
7. Distribution and characterization of rat immunoreactive proadrenomedullin N-terminal 20 peptide (PAMP) and the augmented cardiac PAMP in spontaneously hypertensive rat.
Inatsu H; Sakata J; Shimokubo T; Kitani M; Nishizono M; Washimine H; Kitamura K; Kangawa K; Matsuo H; Eto T
Biochem Mol Biol Int; 1996 Feb; 38(2):365-72. PubMed ID: 8850532
[TBL] [Abstract][Full Text] [Related]
8. Decrease of TSH levels and epithelium/colloid ratio in rat thyroid glands following administration of proadrenomedullin N-terminal peptide (12-20).
Ginda WJ; Nowak KW; Malendowicz LK
Horm Metab Res; 2000 Jan; 32(1):10-4. PubMed ID: 10727007
[TBL] [Abstract][Full Text] [Related]
9. Role of adrenomedullin and related peptides in the regulation of the hypothalamo-pituitary-adrenal axis.
Nussdorfer GG; Rossi GP; Mazzocchi G
Peptides; 1997; 18(7):1079-89. PubMed ID: 9357070
[TBL] [Abstract][Full Text] [Related]
10. Distribution and molecular forms of adrenomedullin and proadrenomedullin N-terminal 20 peptide in the porcine gastrointestinal tract.
Kiyomizu A; Kitamura K; Kawamoto M; Eto T
J Gastroenterol; 2001 Jan; 36(1):18-23. PubMed ID: 11211206
[TBL] [Abstract][Full Text] [Related]
11. Proadrenomedullin N-terminal 20 peptide is rapidly cleaved by neutral endopeptidase.
Nagatomo Y; Kitamura K; Kangawa K; Fujimoto Y; Eto T
Biochem Biophys Res Commun; 1996 Jun; 223(3):539-43. PubMed ID: 8687431
[TBL] [Abstract][Full Text] [Related]
12. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma.
Kitamura K; Kangawa K; Kawamoto M; Ichiki Y; Nakamura S; Matsuo H; Eto T
Biochem Biophys Res Commun; 1993 Apr; 192(2):553-60. PubMed ID: 8387282
[TBL] [Abstract][Full Text] [Related]
13. [Adrenomedullin and PAMP].
Kitamura K; Eto T
Nihon Rinsho; 1997 Aug; 55(8):1963-70. PubMed ID: 9284408
[TBL] [Abstract][Full Text] [Related]
14. Specific binding sites for proadrenomedullin N-terminal 20 peptide (PAMP) in the rat.
Iwasaki H; Hirata Y; Iwashina M; Sato K; Marumo F
Endocrinology; 1996 Jul; 137(7):3045-50. PubMed ID: 8770930
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular and sympathetic effects of proadrenomedullin NH2-terminal 20 peptide in conscious rats.
Saita M; Ishizuka Y; Kato K; Kunitake T; Hanamori T; Kitamura K; Eto T; Kannan H
Regul Pept; 1998 Oct; 77(1-3):147-53. PubMed ID: 9809809
[TBL] [Abstract][Full Text] [Related]
16. Proadrenomedullin NH(2)-terminal 20 peptide, a new product of the adrenomedullin gene, inhibits norepinephrine overflow from nerve endings.
Shimosawa T; Ito Y; Ando K; Kitamura K; Kangawa K; Fujita T
J Clin Invest; 1995 Sep; 96(3):1672-6. PubMed ID: 7657838
[TBL] [Abstract][Full Text] [Related]
17. Proadrenomedullin N-terminal 20 peptide: minimal active region to regulate nicotinic receptors.
Mahata M; Mahata SK; Parmer RJ; O'Connor DT
Hypertension; 1998 Nov; 32(5):907-16. PubMed ID: 9822452
[TBL] [Abstract][Full Text] [Related]
18. Proadrenomedullin N-terminal 20 peptide (PAMP) stimulates aldosterone secretion by the intact rat adrenal glomerulosa by a cAMP-dependent mechanism.
Thomson LM; Kapas S; Hinson JP
FEBS Lett; 1998 Jul; 432(1-2):37-9. PubMed ID: 9710246
[TBL] [Abstract][Full Text] [Related]
19. Expression of proadrenomedullin derived peptides in the mammalian pituitary: co-localization of follicle stimulating hormone and proadrenomedullin N-20 terminal peptide-like peptide in the same secretory granules of the gonadotropes.
Montuenga LM; Burrell MA; Garayoa M; Llopiz D; Vos M; Moody T; García-Ros D; Martínez A; Villaro AC; Elsasser T; Cuttitta F
J Neuroendocrinol; 2000 Jul; 12(7):607-17. PubMed ID: 10849205
[TBL] [Abstract][Full Text] [Related]
20. Proadrenomedullin N-terminal 20 peptide inhibits aldosterone secretion of human adrenocortical and Conn's adenoma cells: comparison with adrenomedullin effect.
Andreis PG; Tortorella C; Mazzocchi G; Nussdorfer GG
J Clin Endocrinol Metab; 1998 Jan; 83(1):253-7. PubMed ID: 9435451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
